Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Current assets    
Cash and cash equivalents $ 10,860 $ 434
Marketable debt securities, available for sale 1,403 926
Escrow receivable 4,812
Accounts receivable, net 2,999 2,010
Inventory 2,138 1,459
Prepaid expenses and other current assets 334 304
Assets held for sale 176
Total current assets 17,910 9,945
Property, plant and equipment, net of accumulated depreciation of $4,899 and $6,252, respectively 2,123 2,329
Secured promissory note receivable 3,000
TOTAL ASSETS 23,033 12,274
Current liabilities    
Accounts payable 836 432
Accrued advertising and other allowances 411 92
Other current liabilities 898 409
Total current liabilities 2,145 933
Non-current liabilities:    
Deferred revenue, net of current portion 137 110
Unsecured convertible promissory notes, net 9,990
Total non-current liabilities 10,127 110
Total liabilities 12,272 1,043
COMMITMENTS AND CONTINGENCIES  
Stockholders' equity    
Preferred stock authorized 1,000,000, $.0005 par value, no shares issued
Common stock authorized 50,000,000, $.0005 par value, issued 28,256,275 and 28,225,615 shares, respectively 14 14
Additional paid-in capital 60,894 60,215
Accumulated deficit (2,653) (1,506)
Treasury stock, at cost, 16,652,022 and 16,652,022 shares (47,490) (47,490)
Accumulated comprehensive loss (4) (2)
Total stockholders' equity 10,761 11,231
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 23,033 $ 12,274